Capital Pro-Égaux Inc., through its wholly owned subsidiary Technique d'usinage Sinlab Inc, files notices for patent infringement

Jun 19, 2012, 15:08 ET from CAPITAL PRO-EGAUX INC.

LACHENAIE, QC, June 19, 2012 /PRNewswire/ - Capital Pro-Égaux Inc. (the "Company") reports that on Thursday June 14th, 2012, the "Company" has filed, through its wholly owned subsidiary Technique d'usinage Sinlab Inc., notices against Nobel Biocare USA, Nobel Biocare Procera USA, Dentsply International Inc, Cagenix Technologies Inc, Materialise Dental Inc, BioHorizons Global HQ, DelCam Holdings and DelCam USA Inc for patent infringement of the "Company" United States Patent Nos. 8,021,153, 7,866,980, 7,331,786, 6,814,575 and 6,382,975.

This notice, amongst various requests, formally requires to immediately ceasing the manufacturing and the selling of manufacturing programs of the superstructure and/or the surgical guide for dental implant placement covered by the patents and to respond in writing by no later than the 5th of July 2012, 17:00 hours. Failure to comply will generate immediate legal proceedings

About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."